Please use a PC Browser to access Register-Tadawul
Evaluating Huron Consulting Group (HURN) After Recent Share Price Cooling And Long Term Gains
Huron Consulting Group Inc. HURN | 145.28 145.28 | -2.00% 0.00% Post |
Recent price moves and business backdrop
Huron Consulting Group (HURN) has seen mixed share performance recently, with a 7.5% gain over the past week contrasting with declines over the month, past 3 months, year to date, and past year.
Against that share price backdrop, the company reports annual revenue of US$1.66b and net income of US$105.04m. These figures reflect its role across healthcare, education, and commercial consulting and software services.
That mix of a recent 7.5% 7 day share price return alongside a weaker 30 day and year to date share price performance, with a 1 year total shareholder return of a 7.25% decline but a 3 year total shareholder return of 76.29%, points to longer term momentum that has cooled in the short term as investors reassess growth and risk around the current US$141.40 share price.
If this kind of pullback after a strong multi year run has you looking wider, it could be a good moment to check out 19 top founder-led companies as potential fresh ideas beyond consulting.
With Huron posting US$1.66b in revenue, US$105.04m in net income and trading at US$141.40, plus a value score of 4 and an indicated intrinsic discount, is there still upside here or is future growth already priced in?
Most Popular Narrative: 34.4% Undervalued
With Huron Consulting Group last closing at $141.40 against a most followed fair value of $215.50, the prevailing narrative sees a sizable valuation gap that hinges on how its earnings and cash generation play out under an outcome based model and ongoing buybacks.
Huron's investments in digital transformation capabilities, proprietary software, and analytics are aligning with accelerating adoption of cloud, AI, and data modernization in the commercial sector, generating record sales conversions and robust project pipelines, supporting sustainable top-line expansion going forward.
Curious what kind of revenue ramp, margin profile, and future earnings multiple are embedded in that fair value? The narrative leans on faster earnings growth, richer profitability and a different P/E than today, but the exact mix of those moving parts may surprise you.
Result: Fair Value of $215.50 (UNDERVALUED)
However, this hinges on healthcare and education clients maintaining budgets, as well as on outcome based and digital projects avoiding delays that could hit revenue and margins.
Another View: What The P/E Is Telling You
So far the story leans on fair value estimates that suggest upside, but the current P/E ratio paints a more cautious picture. Huron trades at 21.4x earnings, which is higher than both its peers at 14.3x and the wider US Professional Services industry at 20.6x.
At the same time, that 21.4x level sits below an estimated fair ratio of 26.6x, which indicates some potential if the market later prices Huron closer to that fair ratio. The tension is clear: is the current premium a sign of overpaying, or a starting point if earnings continue to align with forecasts?
Next Steps
The mix of optimism and caution around Huron is clear, so move quickly, review the numbers for yourself, and weigh up 3 key rewards and 1 important warning sign.
Looking for more investment ideas?
If Huron has sharpened your focus, do not stop here. Broaden your watchlist now so you are not playing catch up when the next opportunity appears.
- Spot potential bargains early by scanning our list of screener containing 24 high quality undiscovered gems that pair solid fundamentals with less crowded investor attention.
- Strengthen the core of your portfolio by focusing on companies in the solid balance sheet and fundamentals stocks screener (39 results) that aim to keep debt and liquidity in check.
- Lock in income potential by reviewing 15 dividend fortresses that combine higher yields with a focus on consistency.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


